Search

Your search keyword '"Seydi, Moussa"' showing total 364 results

Search Constraints

Start Over You searched for: Author "Seydi, Moussa" Remove constraint Author: "Seydi, Moussa"
364 results on '"Seydi, Moussa"'

Search Results

1. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)

2. Accuracy of PHQ-9 against psychiatric diagnosis for depression among people living with HIV: A multicounty cross-sectional study

3. Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial

5. Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa

6. Linear epitope mapping of the humoral response against SARS-CoV-2 in two independent African cohorts

7. Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study

9. Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial

11. Accuracy of nine-item Patient Health Questionnaire against psychiatric diagnosis for depression among people with HIV.

12. Severe dengue in adults and children, Ouagadougou (Burkina Faso), West Africa, October 2015–January 2017

13. Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

14. Effects of the COVID-19 Pandemic on ART Initiation and Access to HIV Viral Load Monitoring in Adults Living With HIV in West Africa: A Regression Discontinuity Analysis.

15. Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants.

16. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

17. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

19. Perceptions, facilitators and barriers to the implementation of interpersonal group therapy to treat depression among people living with HIV in Senegal: a qualitative study

21. Severe Malaria and Risk Factors for Death in the Infectious Diseases Department of the University Hospital of Fann in Dakar, Senegal

22. A Model of the 2014 Ebola Epidemic in West Africa with Contact Tracing

23. Epidemiological, Clinical and Radiological Profile of Patients Hospitalized for COVID-19 at the Epidemic Treatment Centre of the Fann Hospital, Dakar during the Third and Fourth Waves

24. Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trial

26. Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal

27. The impact of food insecurity on HIV outcomes in Senegal, West Africa: a prospective longitudinal study

28. Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study

29. Characteristics, Management, and Outcomes of Bacterial Dermohypodermatitis at the Infectious and Tropical Diseases Department of Fann University Hospital, 2016-2020

30. Metabolic and Immune Consequences of Antibiotic Related Microbiome Alterations during first-line Tuberculosis Treatment in Bamako, Mali

31. High prevalence of binge drinking among people living with HIV in four African countries

32. Rapport du groupe de travail sur les cahiers de laboratoires électroniques

33. COVID-19 Outbreak, Senegal, 2020

35. Tetanus in the Elderly in Dakar: Epidemiological, Clinical, Evolutionary Aspects and Associated Factors of Death

36. Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers

37. Simple treatment eligibility score for chronic HBV infection at peripheral health facilities in sub-Saharan Africa

38. Driving improvements in hepatitis B care in Africa: profile of the hepatitis B in Africa collaborative network (HEPSANET)

42. Neuro-meningeal Tuberculosis in Adult Senegalese Patients: Profile and Outcome of Cases Diagnosed at a Referral Service, from 2015 to 2020

43. Risk Factors for COVID-19 Related Death during the First Three Waves of the Pandemic in an Epidemic Treatment Center at Dakar, Senegal

44. Factors associated with verbal fluency in older adults living with HIV in West Africa: A longitudinal study

45. Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey)

46. Chronic viral hepatitis, <scp>HIV</scp> infection and <scp>Non‐Hodgkin</scp> lymphomas in West Africa, a case‐control study

47. Facteurs associés à la dissociation immunovirologique chez les patients infectés par le VIH-1 sous traitement antirétroviral hautement actif au Centre de Traitement Ambulatoire (CTA) de Dakar

49. Diagnostic performance of non-invasive liver fibrosis biomarkers: a bayesian individual patient data meta-analysis of hepatitis B cohorts in sub-saharan Africa (HEPSANET)

50. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low‐ and middle‐income countries: a multicohort study

Catalog

Books, media, physical & digital resources